Thursday 7 July 2022

08.30 Registration

08.55 Welcome

Jon Green, One Nucleus

09.00 Keynote Presentation

Melanie Lee, LifeArc

09.20 Enabling Bio Innovation

A Keynote presentation and panel to discuss the main technology, human and societal drivers of successful bio innovation. 

Chair: Priya Kalia, SciTribe

David Joyce, Thermo Fisher 

Michael Chen, Nuclera

Jeroen Verheyen, Semarion

Paul Smith, BC Platforms

10.20 Coffee Break

10.50 Bio Innovation in Therapeutics – AI Discovered Drugs in Action

With the first ‘AI discovered’ drugs starting to be approved, our expert panel will discuss how much this game changing technology will impact development life cycles and who may be the biggest winners from its deployment.   

Chair: Julia Gwilt, Appleyard Lees 

Pascal Savy, Charles River 

James Dale, Pharmenable 

Rabia Khan, Ladder Therapeutics

11.40 Bio Innovation in Diagnostics – From Population to Precision

A panel discussion to highlight how the technology developments in omics, biomarkers identification and data collection are shifting the value proposition for diagnostics.  

Chair: James Evans, EY 

Jenny Barnett, Monument Therapeutics 

Santiago Miriuka, MultiplAI Health

Debora Lucarelli, Enhanc3D Genomics

Alison Howie, DNAe

12.30 Lunch

13.30 Bio Innovation in Prevention – the Good, the Bad and the Bugly

After two years focusing mostly on one virus, many innovations in the space of AMR, microbiome or general surveillance were overlooked. This panel will discuss the opportunities now arising in a more holistic approach to human – ‘bug’ interaction. 

Chair: Richard Vickers, tranScrip

Anne Neville, Microbiotica 

Michel de Baar, MSD

Mike Whelan, CEPI 

Martin Stocks, Iceni Glyoscience

14.20 Bio Innovation in Development – Manufacturing Cell and Gene Therapeutics

The panel will discuss key technology advances in manufacture of cell and gene therapies, a crucial topic for those developing therapeutics who hope they will become market leaders.

Chair: Adrian Toutoungi, Taylor Wessing

Angela Osborne, eXmoor Pharma Concepts

Kerstin Papenfuss, Deep Science Ventures

Julie Wood, Thermo Fisher Scientific

Steven Howe, GSK

15.10 Coffee Break

15.45 Keynote Presentation – US Perspective of the Cambridge Life Science Ecosystem

Tim Schoen, BioMed Realty

15.55 Back to the Future – Reinventing Bio Innovation Ecosystems

A presentation and panel reflecting on the key ingredients that create the most successful Bio Innovation Ecosystems and how they must evolve to keep pace with the fast-moving world we live in. 

Chair: Mike Ward, Clarivate 

Andy Neely, University of Cambridge 

Tim Schoen, BioMed Realty

Belinda Clarke, Agri-TechE

James Fry, Mills & Reeve

Wael Muselmani, MedCity  

16.55 Closing Remarks

17.00 Drinks Reception

18.30 End